Key result
Global loss of Nlrx1 attenuated ventricular dysfunction and adverse remodeling and decreased post-infarction mortality, which was associated with increased CD9+IL1rn+ reparative macrophages modulated by CCN2.
Why the study?
The role of Nlrx1 in post-infarction inflammation and healing was poorly understood, and how surviving cardiomyocytes might influence macrophage phenotype and function in infarcted hearts was largely unexplored.
Nlrx1 deficiency in cardiomyocytes promotes a reparative macrophage phenotype via CCN2 secretion, identifying a novel therapeutic target for post-infarction healing.
Nlrx1 inhibition may enhance post-MI repair; hypothesis-generating in mice, human translation untested.
Rationale Nlrx1, a pattern recognition receptor belonging to the NLR family, is highly expressed in the heart and is significantly increased after myocardial infarction in vivo, however, the role of Nlrx1 in post-infarction inflammation and healing is poorly understood. Although the effects of infiltrating macrophages on survival of cardiomyocytes and healing of injured hearts have been intensely studied, whether or not and how surviving cardiomyocytes might influence the phenotype and function of macrophages in the infarcted hearts was largely unexplored. Objective To investigate the role of Nlrx1 in post-infarction inflammation and healing and to dissect the underlying mechanism. Methods and results Single cell RNA-sequencing of 23,805 cells isolated from infarcted hearts revealed 7 clusters of infarct macrophages including CCR2 + , Isg + , Mki67 + proliferative, and LYVE1 + cardiac resident macrophages, and identified a novel subset of CD9 + Il1rn + macrophages, which were characterized by high expression of Cd9, Il1rn, Gpnmb and Spp1, and downregulation of proinflammatory cytokines and chemokines. CD9 + Il1rn + macrophages were largely found in infarcted hearts of Nlrx1KO mice, and were transcriptionally unique with reparative phenotype. Loss of Nlrx1 attenuated ventricular dysfunction and adverse remodeling, and decreased post-infarction mortality. Flow cytometry analysis showed markedly increased number of CD9 + macrophages and higher mean fluorescence intensity of CD9 in Nlrx1KO mice. RNA-seq analysis revealed that CD9 + macrophages of Nlrx1KO infarcted hearts exhibited a reparative and anti-inflammatory phenotype as featured by upregulation of wound healing-associated genes including CD9, Spp1 and Fn1 , and downregulation of proinflammatory genes. Conditioned medium from Nlrx1 deficient cardiomyocytes upon hypoxia stimulation skewed macrophage polarization towards a reparative and inflammation-suppressed phenotype. Gain-and loss-of function of Nlrx1 combined with RNA-seq analysis identified CCN2, whose expression and secretion were significantly increased in Nlrx1 deficient cardiomyocytes upon hypoxia, as a cardiomyocytes-derived mediator responsible, at least partly, for reprograming macrophage towards a reparative phenotype. In vivo, CCN2 expression was markedly elevated in Nlrx1KO infarcted hearts. Moreover, exogenous CCN2 partially mediated macrophage transition towards a reparative phenotype. Conclusions CD9 + IL1rn + macrophages modulated by Nlrx1 deficient cardiomyocytes-derived CCN2, is a novel subset of reparative macrophages contributing to infarct healing. Inhibition of myocardial Nlrx1 and/or activation of CCN2 to boost CD9 + IL1rn + reparative macrophages may represent new therapeutics for infarct healing following ischemic injury.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied Myocardial infarction. Nlrx1 knockout vs. Wild-type mice was evaluated on Ventricular dysfunction, adverse remodeling, and post-infarction mortality. Global loss of Nlrx1 attenuated ventricular dysfunction and adverse remodeling and decreased post-infarction mortality, which was associated with increased CD9+IL1rn+ reparative macrophages modulated by CCN2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: